St. Luke s Health System s (SLHS) Cancer Institute in Boise, ID seeks a BC/BE Hematologist/ Oncologist with specific interest in adult hematological malignancies and cell therapy. Our Hematologic Malignancies and Blood and Marrow Transplantation Program became a free-standing program within SLHS in April 2018, FACT accredited in 1993 (Autologous) and in 2019 (Allogeneic) for performing hematopoietic stem cell transplantation, with CAR-T cell treatment starting in April 2022. Our dedicated heme malignancy and cell therapy program is the only such program in the state of Idaho, and in addition to treating Idaho patients, also treats patients from bordering states such as eastern Oregon, western Montana, Wyoming and northeast Nevada. The program is an NMDP Transplant Center , an NMDP Apheresis Collection Center and is fully FACT accredited, offering all types of allogeneic hematopoietic stem cell transplantation integrated with a vibrant acute leukemia treatment program. The program further functions as an academic tertiary heme-malignancy and cell therapy program but officially is non-academic due to having no university affiliated medical school in Idaho. The successful candidate will join a vibrant, busy, and rapidly growing program composed of a cohesive dedicated team dedicated to bringing state-of-the art treatments to patients living in urban centers with no academic medical center, as well to surrounding rural areas.

Patients and their families have trusted St. Luke's Cancer Institute for more than 50 years. It provides care to a vast rural area through five cancer centers dedicated to state-of-the-art treatment and affiliated with St. Luke s regional medical centers throughout western Idaho. Our main cancer center in Boise has separate radiation oncology specialists and subspecialized oncological surgery. We are also home to Idaho s only pediatric oncology program with ample opportunities for collaboration on AYA patients on pediatric/AYA protocols (and candidates for cell therapy).
For more information on this opportunity, please contact Josh Rees via email: or phone: